(Total Views: 247)
Posted On: 04/06/2022 9:54:08 PM
Post# of 1418
Well, so much for boosters...
U.S. FDA aims to decide on strain selection for COVID boosters by June
""We're going to have to think about this in a way that is less than optimal because we're not going to have all the data that we'd like to have," Peter Marks, director of FDA's Center for Biologics Evaluation and Research, said at a meeting of the agency's scientific advisers to discuss the issue."
Marks also conceded that future COVID booster campaigns likely need to be less frequent. The FDA recently approved a fourth round of shots for older Americans.
"We simply can't be boosting people as frequently as we are and I'm the first to acknowledge that this additional fourth booster dose that was authorized was a stopgap measure," he said.
https://news.yahoo.com/u-fda-says-current-cov...06704.html
U.S. FDA aims to decide on strain selection for COVID boosters by June
""We're going to have to think about this in a way that is less than optimal because we're not going to have all the data that we'd like to have," Peter Marks, director of FDA's Center for Biologics Evaluation and Research, said at a meeting of the agency's scientific advisers to discuss the issue."
Marks also conceded that future COVID booster campaigns likely need to be less frequent. The FDA recently approved a fourth round of shots for older Americans.
"We simply can't be boosting people as frequently as we are and I'm the first to acknowledge that this additional fourth booster dose that was authorized was a stopgap measure," he said.
https://news.yahoo.com/u-fda-says-current-cov...06704.html
(1)
(0)
